Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXSR9D
|
||||
Drug Name |
4-(3-Bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-piperazine-1-carboxylic acid (1-methyl-piperidin-4-yl)-amide
|
||||
Synonyms |
CHEMBL352653
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H31BrClN5O
|
||||
Canonical SMILES |
CN1CCC(CC1)NC(=O)N2CCN(CC2)C3c4ccc(Cl)cc4CCc5cc(Br)cnc35
|
||||
InChI |
InChI=1S/C25H31BrClN5O/c1-30-8-6-21(7-9-30)29-25(33)32-12-10-31(11-13-32)24-22-5-4-20(27)15-17(22)2-3-18-14-19(26)16-28-23(18)24/h4-5,14-16,21,24H,2-3,6-13H2,1H3,(H,29,33)
|
||||
InChIKey |
DPUOYNLDETWCLN-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.